A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

January 31, 2003

Study Completion Date

February 28, 2003

Conditions

Painful Diabetic Neuropathy

Interventions

DRUG

SPM927/Lacosamide

SPM927 (film-coated tablets, 25/50/100mg per tablet), dosage 400mg/day, intake in the morning and in the evening, intake for 10 weeks

OTHER

Placebo

Placebo tablets two times a day for 10 weeks